Digital Health Coffee Time Briefing ☕

Your morning summary of digital health news, information and events to know about if you want to be “in the know”.

👇 News

🩻 Teleradiology provider Hexarad has expanded its capacity for its subspecialty reporting and improved its efficiency. The move comes following growing demand from NHS and private healthcare customers, who want access to subspecialty reporting, but may lack the expertise needed in their in-house teams. Using Hexarad’s AI-driven platform, hospitals can connect with a pool of expert radiologists via  an auto-allocation tool.

👨‍👩‍👦‍👦 Pharmacy2U has launched a Family Accounts service, providing a single online destination for the UK’s 5.8 million unpaid carers as well as family members who are managing loved ones’ prescriptions. The service is an evolution to its Carer Accounts platform and aims to remove barriers to access. Users will be able to set up multiple profiles, manage prescriptions and arrange tracked delivery of medication for free.

🧠 A partnership between Brainomix and 3DR Labs has been announced, which aims to advance stroke care in the US through the Brainomix 360 Stroke solution. The AI-powered platform delivers insights to enhance treatment decisions. It will be integrated into 3DR’s AI Labs – a vendor-agnostic platform that combines AI with integrated human intelligence.

💨 Pharmaceutical companies will be able to start using a first-of-its-kind inhaler in Phase 1 clinical trials from Q4 2025. CHI’s Quattrii is the first-ever dry powder inhaler engine that is able to deliver large volumes of biologic and mRNA molecules in a single inhalation. Quattrii says that it will enable next-gen inhaled biologics for novel therapies by reshaping respiratory drug delivery.

🏙️ F2G has relocated its full UK operations to Alderley Park, the UK’s largest single-site life science campus, owned by Bruntwood SciTech. Following its $100m, Series H funding round, the antifungal biopharma company is bringing together its R&D and office teams, in a 3,000sq ft specialist lab space. The move marks the next phase of growth for F2G as it advances it clinical and regulatory plans.

❓Did you know?

A recent BMA survey revealed that 61% of the public have little to no confidence in cutting Emergency Department waits to under four hours, and 65% feel the same about restoring the 18-week treatment target.

The figures, announced at the BMA’s annual conference in Liverpool on 23 June, underscore challenges in system performance.

This public scepticism also extends to workforce issues, with more than 90% of respondents deeming it “important” or “very important” for the government to address ongoing doctor unemployment.

📖 What we’re reading

Research, published on 26 June 2025, has revealed that despite the announcement of a further £10bn government investment into digital transformation, the UK is one of Europe’s least trusting nations when it comes to adopting AI and digital health tools.

STADA’s independently conducted Health Report 2025, found that 52% of UK adults would not consider using AI for a medical consultation, with concerns over data storage and accuracy being major barriers.

How data is stored was a concern for 24% of UK adults, in comparison to the global average of 16% and 61% of UK respondents said they do not trust AI to deliver accurate or safe medical advice.

Volker Sydow, interim general manager for STADA Thornton & Ross, said: “AI is a huge topic on the agenda for global healthcare, and it is worrying to see such low trust levels in the UK.

“While there’s clear resistance to digital transformation, projections suggest that the UK’s health and social care sectors could see the biggest job gains from AI over the next two decades.”

🚨Upcoming events

17-18 July, University of Warwick – Summer Schools 2025